Abstract
Ehrlichia chaffeensis, an obligatory intracellular rickettsial pathogen, enters and replicates in monocytes/macrophages and several non-phagocytic cells. E. chaffeensis entry into mammalian cells is essential not only for causing the emerging zoonosis, human monocytic ehrlichiosis, but also for its survival. It remains unclear if E. chaffeensis has evolved a specific surface protein that functions as an ‘invasin’ to mediate its entry. We report a novel entry triggering protein of Ehrlichia, EtpE that functions as an invasin. EtpE is an outer membrane protein and an antibody against EtpE (the C-terminal fragment, EtpE-C) greatly inhibited E. chaffeensis binding, entry and infection of both phagocytes and non-phagocytes. EtpE-C-immunization of mice significantly inhibited E. chaffeensis infection. EtpE-C-coated latex beads, used to investigate whether EtpE-C can mediate cell invasion, entered both phagocytes and non-phagocytes and the entry was blocked by compounds that block E. chaffeensis entry. None of these compounds blocked uptake of non-coated beads by phagocytes. Yeast two-hybrid screening revealed that DNase X, a glycosylphosphatidyl inositol-anchored mammalian cell-surface protein binds EtpE-C. This was confirmed by far-Western blotting, affinity pull-down, co-immunoprecipitation, immunofluorescence labeling, and live-cell image analysis. EtpE-C-coated beads entered bone marrow-derived macrophages (BMDMs) from wild-type mice, whereas they neither bound nor entered BMDMs from DNase X-/- mice. Antibody against DNase X or DNase X knock-down by small interfering RNA impaired E. chaffeensis binding, entry, and infection. E. chaffeensis entry and infection rates of BMDMs from DNase X-/- mice and bacterial load in the peripheral blood in experimentally infected DNase X-/- mice, were significantly lower than those from wild-type mice. Thus this obligatory intracellular pathogen evolved a unique protein EtpE that binds DNase X to enter and infect eukaryotic cells. This study is the first to demonstrate the invasin and its mammalian receptor, and their in vivo relevance in any ehrlichial species.
Author Summary
Human monocytic ehrlichiosis (HME), discovered in 1986, was designated as a nationally notifiable disease by Centers for Disease Control and Prevention in 1998. HME is one of the most prevalent, life-threatening emerging infectious diseases in the United States. HME is caused by a bacterium, Ehrlichia chaffeensis and is transmitted by the bite of infected ticks. This bacterium has special ability to enter and replicate inside human white blood cells and this feature is very essential for the bacterial survival. How E. chaffeensis enters host cells has been a mystery. The present study revealed that E. chaffeensis outer-surface protein named EtpE binds a specific host cell-surface protein, DNase X, and this ligand-receptor interaction is required to induce bacterial entry into its host cells. In order to test whether E. chaffeensis infection can be prevented by EtpE immunization, mice were immunized with the recombinant EtpE protein, and challenged with live E. chaffeensis. Infection was significantly reduced in the EtpE protein-immunized mice compared to controls. Mice lacking DNase X were also resistant to infection. This study shows EtpE-mediated entry pathway of E. chaffeensis is important in infecting mammals and EtpE can be incorporated into a future HME vaccine design.
Introduction
Ehrlichia chaffeensis causes human monocytic ehrlichiosis (HME), an emerging tick-borne zoonosis. From the site of infected tick bite on human skin, E. chaffeensis infects monocytes and spreads via the bloodstream to various tissues, causing a systemic febrile disease. HME is characterized by fever, headache, myalgia, thrombocytopenia, leucopenia, and elevated liver-enzyme levels, but complications such as pulmonary insufficiency, renal failure, encephalopathy, and disseminated intravascular coagulation can cause death [1]. Early diagnosis and the proper treatment with doxycycline are critical to prevent complications. The disease is of particular threat to the immunocompromised and the elderly people [1].
E. chaffeensis is a small obligatory intracellular bacterium. It belongs to the family Anaplasmataceae in the order Rickettsiales that includes many understudied pathogens of veterinary and public health importance [2]. By electron microscopy, E. chaffeensis is a polymorphic bacterium (0.2–2.0 µm in diameter), and can be morphologically categorized as small dense-cored cells (DCs) or large reticulate cells (RCs) [3]. DCs are ∼0.2–0.5 µm in diameter, which is close to the size of the elementary body of Chlamydia and larger viruses such as Vaccinia virus. By light microscopy, it is not possible to distinguish individual RCs and DCs, since E. chaffeensis aggregates inside eukaryotic host cells. The characteristic clump of intracellular E. chaffeensis organisms is termed as “morula” (mulberry in Latin) [2]. However, when they are freshly isolated from host cells and dispersed, smaller bacteria (<0.5 µm) are more densely stained with basic dye than larger bacteria (>0.5 µm); therefore, they were defined as DCs and RCs, respectively [4]. DCs are more resistant to strong sonication and more infectious than RCs [5]. In cell culture, a biphasic developmental cycle has been reported: initially small infectious DCs bind to and internalize into host cells, which then develop into larger replicating RCs inside a membrane-lined compartment that resembles early endosomes. After replication in expanding inclusions, the mature RCs transform back into DCs prior to release from the host cells [4], [5]. In patients' blood specimens, monocytes were primarily infected with E. chaffeensis, and hence, the disease was named as “monocytic ehrlichiosis” to distinguish it from “granulocytic ehrlichiosis” caused by infection with granulocyte-tropic Ehrlichia sp. [1]. E. chaffeensis can replicate well in several mammalian cell lines including canine histiocytic leukemia (DH82), human acute leukemia (THP-1), human promyelocytic leukemia (HL-60), human embryonic kidney (HEK293), and monkey endothelial (RF/6A) cells [6]–[8].
Entry into the permissive eukaryotic host cells is essential for E. chaffeensis to sustain its life, since its small genome of 1.18 Mb lacks a large portion of metabolic genes that are required for free living [9]. E. chaffeensis also lacks LPS, peptidoglycan, lipoteichoic acid, and flagella that engage Toll-like or NOD-like receptors, or scavenger receptors [2], [10]. E. chaffeensis entry and subsequent infection of THP-1 cells, but not binding are almost completely inhibited by monodansylcadaverine (MDC), a transglutaminase inhibitor [11]. MDC is known to block Neorickettsia risticii (formerly Ehrlichia risticii) entry and infection of P388D1 cells, vesicular stomatitis virus uptake and receptor-mediated endocytosis of α2-macroglobulin by Swiss 3T3 mouse cells, but not the uptake of latex beads by P388D1 mouse macrophages [12]–[14]. E. chaffeensis entry into THP-1 cells, leading to productive infection, is dependent on the host-cell surface lipid rafts and glycosylphosphatidyl inositol (GPI)-anchored proteins [15]. Furthermore, lipid raft-associated protein caveolin-1, but not clathrin localizes to the E. chaffeensis entry site [15]. After entry, E. chaffeensis replicates in the membrane-bound compartment resembling an early endosome as it contains early endosome antigen 1 (EEA1), Rab5, and transferrin receptor [6]. Several intracellular bacteria are known to enter host cells by using their specific surface protein collectively called as ‘invasin’ or ‘internalin’ [16]. However, detailed mechanisms of E. chaffeensis entry are unknown; particularly regarding the involvement of any specific bacterial surface protein that can function as an invasin and its cognitive host-cell receptor [2].
The comparative genome hybridization study of E. chaffeensis strains revealed that a hypothetical protein, ECH1038, consists of highly conserved N- and C-terminal segments flanking its strain-variable central region [17]. ECH1038 expression is up-regulated in the DC stage of E. chaffeensis [18]. In this study, we uncovered that ECH1038 (here named as entry triggering protein of Ehrlichia, EtpE), particularly its C-terminal conserved region (EtpE-C), is critical for E. chaffeensis binding, entry, and infection of several different host cell types. In order to study whether EtpE-C can mediate the invasion into permissive host cells in the absence of other E. chaffeensis factors, we used latex beads coated with EtpE-C. The coated beads entered both phagocytes and non-phagocytes in a manner similar to E. chaffeensis entry. Subsequent investigation led to the discovery that DNase X, a host cell surface GPI-anchored protein, is the receptor of EtpE-C mediating the entry of E. chaffeensis into several mammalian cell types permissive to its replication.
Results
ECH1038 (EtpE) is highly expressed by E. chaffeensis in mammalian cells
ECH1038 (GenBank accession no. YP_507823, EtpE) consists of 1963 amino acid residues (Mr 222,638, pI: 7.0) and is predicted to be an outer membrane protein with an N-terminal secretion signal by PSORT analysis [17]. Although EtpE is variable in the central ∼950 residues, the N-terminal ∼700 residues and C-terminal ∼300 residues are conserved among multiple E. chaffeensis strains of distinct virulence, suggesting that these two regions are indispensable for E. chaffeensis. The amino acid sequence alignment of EtpE orthologs in the three strains of E. chaffeensis, Arkansas, Wakulla, and Liberty are shown (suppl. Fig. S1). Amino acid sequence alignment of EtpE orthologs among three genome-sequenced Ehrlichia species, E. chaffeensis Arkansas, E. canis Jake and E. ruminantium Welgevonden, revealed that while most of the N-terminal proximal region was conserved also among Ehrlichia species, the C-terminal region was not (suppl. Fig. S2).
To begin probing EtpE function, we cloned N-terminal (residues 29–708) and C-terminal (residues 1658–1965) of EtpE as C-terminal histidine-tagged fusion proteins (rEtpE-N and rEtpE-C) and antisera were prepared against rEtpE-N and rEtpE-C. Western blot analysis using these antibodies showed that full-length EtpE was expressed by E. chaffeensis in DH82 cells (Fig. 1A). DH82 cells were initially used, since this cell line has been successfully used to culture isolate E. chaffeensis from the blood of HME patients [19], [20].
To determine whether EtpE is expressed by E. chaffeensis in human monocytes, the pathogen's primary in vivo target cells, EtpE expression was determined in E. chaffeensis cultured in human primary macrophages derived from peripheral blood monocytes by double immunofluorescence labeling after paraformaldehyde (PFA) fixation and saponin permeabilization. E. chaffeensis major outer membrane protein P28 [21] was used as positive control to label the bacterial membrane. The results showed that EtpE was abundantly expressed by E. chaffeensis in human macrophages, and localized at bacterial membrane like P28 [21] (Fig. 1B).
EtpE is exposed on the E. chaffeensis surface, and anti-EtpE-C inhibits E. chaffeensis binding, entry, and infection
P28 is bacterial surface exposed [21] and is a β-barrel protein that functions as porin [22]. To determine whether EtpE is exposed on the bacterial surface, double immunofluorescence labeling with anti-EtpE-C and anti-P28 was performed after PFA fixation without saponin permeabilization using E. chaffeensis bound to the surface of DH82 cells. Unlike methanol or acetone fixation, PFA fixation does not allow antibody penetration across biological membranes unless with subsequent permeabilization, thereby limiting antibody staining to molecules exposed to the cell surface [23]. The result showed labeling of both EtpE and P28 (Fig. 1C). Of note, labeled EtpE on E. chaffeensis had a beaded (rosary-like) pattern encircling individual bacterium, in contrast to P28 that had a uniform ring pattern (Fig. 1C). When host cell-free bacteria were treated with pronase E, the surface immunofluorescence staining of EtpE was abolished, but not of CtrA which is an E. chaffeensis cytosolic response regulator of a two-component system [18] (suppl. Fig. S3). These data indicate the surface exposure of EtpE. In contrast to the punctate labeling pattern of EtpE in host cell-bound bacteria, homogeneous labeling of EtpE was observed on host cell-free bacteria (suppl. Fig. S3).
Given the surface exposure of EtpE on E. chaffeensis, we examined whether the antibody against EtpE inhibits binding, entry, and infection of E. chaffeensis. Among the several host cell types used in this study, primary monocytes, macrophages, and myelocytic leukemia cell lines (DH82 and THP-1 cells) are referred to as phagocytes. Phagocytes are very efficient in bacteria and particle uptake as they have an array of dedicated phagocytic receptors, including pathogen pattern recognition receptors, mannose receptors, scavenger receptors, receptors for immunoglobulin (FcR) and complement (CR3) that utilize opsonins for ingestion, to name a few [10], [24]. The other two cell lines used in this study, RF/6A endothelial and HEK293 epithelial cells, are referred to as non-phagocytes, since they lack these features. We first used non-phagocytes to study the effect of in vitro antibody neutralization of EtpE as they lack the response to opsonization and will not readily take-up opsonized particles. E. chaffeensis was pre-incubated with mouse anti-EtpE-C or preimmune mouse sera, and then incubated with RF/6A cells. Binding and entry were determined by immunofluorescence labeling of E. chaffeensis with anti-P28 at 30 min and 2 h post-incubation/infection (pi), respectively. Infection was determined at 48 h pi by quantitative real-time PCR (qPCR). Anti-EtpE-C blocked E. chaffeensis binding, entry, and subsequently infection by approximately 80% compared to preimmune serum (Fig. 1, D–F). Similar level of inhibition of binding and entry was observed using mouse anti-EtpE-C in phagocytic cells such as human THP-1 cells (suppl. Figs. S4A and S4B) and canine DH82 cells (data not shown). This suggests that human or canine FcR-mediated entry of E. chaffeensis opsonized with mouse anti-EtpE-C was negligible in this experiment. Immunization of mice with recombinant P28, which functions as a porin [22], protects mice from E. chaffeensis challenge [21]. Additionally, in a mouse model of HME, immunization of mice with Ehrlichia muris P28 conferred protection from E. muris challenge [25]. As another control, to rule out the possibility that inhibition of binding is a general property of antibody neutralization of any E. chaffeensis cell surface proteins, we examined whether antibody against P28 blocks E. chaffeensis binding and entry. Our result showed antibody (Fab fragment) against P28 did not block binding or entry of E. chaffeensis (suppl. Fig. S5A and S5B). Taken together, these results suggest that EtpE-C potentially serves as an invasin to trigger E. chaffeensis entry in both phagocytes and non-phagocytes.
EtpE is predicted to be anchored on the bacterial outer membrane at its N-terminus, based on analysis using the PRED-TMBB webserver [17], [26]. In contrast to anti-EtpE-C, anti-EtpE-N-pretreatment reduced E. chaffeensis infection by only 20% (suppl. Fig. S6A). Since both anti-EtpE-N and anti-EtpE-C reacted with native EtpE protein from E. chaffeensis equally well by Western blot analysis, we tested accessibility of anti-EtpE-N to EtpE molecules on live E. chaffeensis surface. For this purpose, we freshly prepared the host cell-free E. chaffeensis and incubated with the antibodies without pre-fixation. The result showed that E. chaffeensis was not as readily labeled with anti-EtpE-N as with anti-EtpE-C (suppl. Fig. S6B), suggesting that the antibody access to the N-terminal conserved region might be limited in the native conformation of EtpE in live E. chaffeensis.
EtpE is expressed in HME patients and infected dogs, and immunization with rEtpE-C suppresses E. chaffeensis infection in mice
Because EtpE is highly expressed by E. chaffeensis in mammalian cells in vitro, we next examined whether EtpE is expressed in vivo by Western blot analysis of defined HME patient sera [27]. Equal quantities of rEtpE-N and rEtpE-C (GelCode Blue staining shown in Fig. 2A) were used as antigens in the assay. Patient sera recognized both rEtpE-N and rEtpE-C, whereas the control serum from a healthy individual in an HME non-endemic region did not react with the recombinant proteins (Fig. 2B). Similarly, sera from dogs experimentally infected with E. chaffeensis [28], that were previously shown to recognize E. chaffeensis OmpA [18] and other E. chaffeensis lipoproteins [28], recognized both rEtpE-N and rEtpE-C, but the control dog serum did not (Fig. 2B). These data indicated that EtpE is expressed by E. chaffeensis in vivo during infection of its natural hosts, humans and dogs, and that an antibody (humoral) response is mounted against this protein during infection and disease.
Previous studies showed that antibodies contribute to immunity against E. chaffeensis in immunocompetent mice [29]. Given the facts that anti-EtpE-C neutralized E. chaffeensis binding, consequently entry and infection in vitro, EtpE was expressed by E. chaffeensis in vivo and that a humoral immune response was mounted in infected mammals, we decided to examine whether rEtpE-C immunization could confer protection in mice from E. chaffeensis challenge. C3H/HeJ strain of mice was used, since this strain was reported to serve as a useful model for studying E. chaffeensis infection [30]. At 10 days after the last immunization, all mice were challenged intraperitoneally with E. chaffeensis. The E. chaffeensis load in the blood from rEtpE-C-immunized mice at 5 days post challenge was significantly lower than that of non-immunized mice (Fig. 2C). These results indicate that rEtpE-C is a protective immunogen relevant in E. chaffeensis infection in vivo.
Entry of rEtpE-C-coated beads into macrophages is blocked by compounds that block E. chaffeensis invasion
Bacterial surface exposure of EtpE-C and effectiveness of EtpE-C as the target for both in vitro and in vivo neutralization suggest that EtpE-C may mediate E. chaffeensis invasion. To investigate this possibility, we utilized fluorescent latex beads of average size of 0.5 µm (similar to the size of infectious DCs of E. chaffeensis) coated with rEtpE-C protein. The presence of rEtpE-C on beads was confirmed by dot-blot analysis (data not shown) and immunofluorescence labeling with antiserum against EtpE-C (Fig. 3A). Beads were incubated with mouse bone marrow-derived macrophages (BMDMs) for 45 min followed by trypsin treatment to remove beads that were not internalized. Mouse BMDMs were used here, also to serve as the wild-type control for the later studies using BMDMs from mutant mice. rEtpE-C-coated beads entered BMDMs (Figs. 3B and 3C). Treatment with MDC, genistein (broad-spectrum protein tyrosine kinase inhibitor), or phosphatidylinositol-specific phospholipase C (PI-PLC that removes GPI-anchored proteins from the cell surface) blocks E. chaffeensis entry and infection of THP-1 cells [11], [15]. The entry of rEtpE-C-coated beads into BMDMs was almost completely blocked by these treatments (Figs. 3B and 3C), suggesting rEtpE-C-coated beads enter BMDMs by the same signaling pathway as E. chaffeensis does. The latex bead is well-known to be taken up by macrophages and has been used as a model to study phagocytosis [31]. In striking contrast, entry of non-coated beads into BMDMs was not blocked by any of these treatments (Fig. 3D).
rEtpE-C-coated beads enter non-phagocytes
Non-coated beads did not bind or enter RF/6A and HEK293 non-phagocytic cells (HEK293 cell data are shown in Fig 4B). Remarkably, rEtpE-C-coated beads did readily bind and enter non-phagocytes (HEK293 data are shown in Figs. 4A and 4B). Beads coated with other recombinant E. chaffeensis proteins including rEtpE-N, rECH0825 (a type IV secretion effector protein) [7] or rECH0365 (GroEL) did not bind HEK293 cells (Figs. 4A and 4B), indicating binding and entry of beads into non-phagocytes was due to specific coating with EtpE-C. Scanning and transmission electron microscopy revealed that rEtpE-C-coated beads bound to RF/6A cells were associated with filopodia-like membrane projections (Figs. 4C and 4D left panel) similar to those surrounding E. chaffeensis bound to DH82 cells [4]. Transmission electron microscopy of RF/6A cells incubated with rEtpE-C-coated beads verified that the beads were indeed internalized into RF/6A cells (Fig. 4D right panel). MDC, genistein, and verapamil (a Ca2+ channel blocker) that block E. chaffeensis entry into THP-1 cells [11], also blocked E. chaffeensis entry into RF/6A cells (suppl. Fig. S7, MDC data is shown). Treatment with any of these compounds almost completely blocked the entry of rEtpE-C-coated beads into RF/6A cells (Figs. 4E and 4F). Once internalized, E. chaffeensis-containing vacuoles acquire characteristics of early endosomes [6]. To determine whether rEtpE-C-coated beads were delivered to early endosomes, immunofluorescence labeling was used to visualize the spatial relationship of the early endosomal marker, EEA1 with the rEtpE-C-coated beads, and observed by deconvolution microscopy. Individual as well as multiple beads were seen encased by EEA1-labeled membranous compartment, suggesting that some beads were in endosomes (Fig. 4G). These results indicate that EtpE-C is an invasin, and even in the absence of any other E. chaffeensis factors, EtpE-C alone is sufficient to mediate the binding and entry of EtpE-C-coated beads into non-phagocytic cells.
EtpE-C binds DNase X
Since EtpE-C could mediate binding and entry of EtpE-C-coated beads, we next searched for the potential host-cell receptor for EtpE-C. We cloned EtpE-C into the yeast two-hybrid bait vector and screened a human bone marrow cDNA prey library to identify interacting proteins. Of the 5 clones detected and sequenced, all of them encoded a protein, deoxyribonuclease 1-like 1 (DNase 1L1, DN1L1, or DNase X on chromosome Xq28, GenBank accession no: X90392, 302 residues). One of the clones contained an additional plasmid encoding S-adenosyl methionine-dependent methyltransferase but the coding sequence was out-of-frame; this prey construct alone did not support yeast growth when co-transformed with bait vector to test their interaction. All sequence hits corresponded to the C-terminal fragment of DNase X (residues 105–302). DNase X, one of the human DNase I–family endonucleases, is expressed on the cell surface as a GPI-anchored protein and also localized at early endocytic vesicles, endoplasmic reticulum, and Golgi [32], [33].
To confirm EtpE-C binding to the native human DNase X, we performed far-Western blot analysis. DNase X from the THP-1 cell lysate bound to re-natured rEtpE-C on a nitrocellulose membrane, whereas DNase X did not bind the control rECH0825 (Fig. 5A). Next, we utilized a protein pull-down assay wherein THP-1 cell lysate was applied to rEtpE-C bound to and renatured on a Ni-affinity matrix. Western blotting showed that native DNase X from the lysate bound to rEtpE-C, but not to the control rECH0825 (Fig. 5B). In addition, co-immunoprecipitation showed that anti-EtpE-C, but not the control mouse IgG pulled down native DNase X from the lysate of THP-1 cells incubated with E. chaffeensis for 30 min (Fig. 5C). Taken together, these results indicate that EtpE-C can bind to DNase X.
We fixed RF/6A or HEK293 cells incubated with rEtpE-C-coated beads, and without membrane permeabilization, immunofluorescence labeled cell surface-exposed DNase X. DNase X localized to the areas on the surface of cells where rEtpE-C-coated beads were present (RF/6A cell image shown in Fig. 5D). Time-lapse live-cell image analysis of rEtpE-C-coated beads bound to RF/6A cells ectopically expressing DNase X-GFP at 4°C showed that, upon warming up to 37°C, the initially separated DNase X-GFP signal and beads became closer and overlapped within 5 min (Fig. 5E; see also suppl. Movie S1). The fluorescence intensity profile analysis of red (rEtpE-C-coated beads) and green (DNase X-GFP) signal along the length of the line also revealed that the signals separated at initial time points converged in a few min after warming-up (Fig. 5F).
Binding and internalization of rEtpE-C-coated beads is dependent on DNase X
Since DNase X localized to EtpE-C-coated beads in non-phagocytes, we next examined this phenomenon in phagocytes. Human primary macrophages derived from peripheral blood monocytes were incubated with rEtpE-C-coated or non-coated beads, cell surface exposed DNase X was immunofluorescence-labeled without permeabilization and the distribution of beads and DNase X was examined by deconvolution microscopy. Surface DNase X was seen clustered with rEtpE-C-coated beads; whereas both surface DNase X and beads were randomly dispersed with non-coated beads (image in a single z-plane shown in Fig. 6A). Orthogonal views of the cell from the reconstructed 3D view of serial z-stack images unequivocally demonstrated colocalization of DNase X with rEtpE-C-coated beads (Fig. 6B left panel, see also 3D view in suppl. Movie S2), whereas DNase X did not colocalize with non-coated beads (Fig. 6B right panel, see also 3D view in suppl. Movie S3). The intensity profile analysis of green (DNase X) and red (beads) signals of a single optical section showed that DNase X coincided with rEtpE-C-coated beads, but not with non-coated beads (Fig. 6B right panels). Similar results were observed with canine primary macrophages derived from peripheral blood monocytes and DH82 cells (suppl. Fig. S8). These results indicate DNase X localizes to rEtpE-C-coated beads in primary human and canine macrophages, the pathogen's in vivo target cells.
rEtpE-C-coated beads entered wild-type mouse BMDMs as shown in Figs. 3B and 3C. Therefore, we next examined whether rEtpE-C-coated beads can enter BMDMs from congenic DNase X−/− mice. Beads were incubated with BMDMs from DNase X−/− mice for 45 min followed by trypsin treatment to remove beads that were not internalized. Results showed rEtpE-C-coated beads did not enter DNase X−/− BMDMs (Figs. 6C and 6D). In striking contrast, non-coated beads freely entered DNase X−/− BMDMs (Figs. 6C and 6D). This lack of entry of rEtpE-C-coated beads into DNase X−/− BMDM, but not into the wild-type BMDM, was a direct consequence of its failure to bind DNase X−/− BMDM (suppl. Fig. S9). This phenomenon was specific to rEtpE-C coated beads, because neither the non-coated beads nor the rECH0825-coated beads showed any defect in binding DNase X−/− BMDMs (suppl. Fig. S9). Taken together, these results indicate that rEtpE-C coating dictates the latex bead binding and entry via DNase X-dependent pathway.
DNase X mediates E. chaffeensis binding, entry, and infection
Since DNase X was localized to EtpE-C-coated bead entry foci, we next examined whether DNase X localizes to the E. chaffeensis entry foci as well. Double immunofluorescence labeling of non-permeabilized DH82 cells and primary human macrophages derived from human peripheral blood monocytes showed surface DNase X colocalization with the bound E. chaffeensis (Figs. 7A and 7B). DNase X also localized to the areas of E. chaffeensis binding on THP-1 cells (data not shown). When DH82 cells were pre-incubated with monoclonal anti-DNase X IgG to block the surface-exposed DNase X, E. chaffeensis binding, entry, and overall infection were significantly reduced compared with the control mouse IgG-treated DH82 cells (Figs. 7C–7E). Next, we utilized a small interfering RNA (siRNA) against DNase X to reduce the expression of endogenous DNase X in HEK293 cells (Fig. 7F). Suppression of DNase X expression significantly reduced E. chaffeensis infection in HEK293 cells (Fig. 7G). Moreover, E. chaffeensis binding and entry were reduced by 60% in DNase X−/− BMDMs compared to the wild-type BMDMs (Fig. 7H). E. chaffeensis load at 56 h pi was significantly lower in DNase X−/− BMDMs compared to the wild-type BMDMs (Fig. 7I). These results demonstrated that effective E. chaffeensis binding, entry, and infection depended on DNase X. Importantly, E. chaffeensis load in peripheral blood at 5 days pi in DNase X−/− mice was significantly lower than in wild-type mice (Fig. 7J), indicating that effective in vivo infection of E. chaffeensis also requires involvement of DNase X.
Discussion
E. chaffeensis entry of permissive host cells is an absolute requisite, not only in the pathogenesis of HME, but also for the very existence of the bacterium in nature owing to its inability to survive outside of eukaryotic cells. The present study showed that E. chaffeensis surface protein EtpE is not only an adhesin that binds a specific receptor DNase X, a GPI-anchored mammalian cell surface protein, but also an invasin that subsequently mediates bacterial internalization. E. chaffeensis entry into phagocytes and non-phagocytes was similar, but completely different from the phagocytosis of non-coated latex beads. Differences include 1) ability of E. chaffeensis to bind and enter non-phagocytes vs. inability of non-coated beads to enter non-phagocytes, 2) inhibition of E. chaffeensis entry into phagocytes and non-phagocytes by MDC, genistein, verapamil, and PI-PLC vs. lack of inhibition of entry of non-coated beads into phagocytes by these compounds, 3) DNase X-dependent entry of E. chaffeensis into phagocytes and non-phagocytes, vs. DNase X-independent entry of non-coated beads into phagocytes, and 4) colocalization of DNase X and E. chaffeensis during entry vs. lack of colocalization of non-coated beads with DNase X. Remarkably, coating with a fragment of a single protein, EtpE-C made the beads to bind and enter non-phagocytes and phagocytes like E. chaffeensis does. Similarities between EtpE-C-coated beads and E. chaffeensis include 1) signaling pathways for invasion sensitive to MDC, genistein, verapamil, and PI-PLC, 2) DNase X-dependent adhesion and invasion, 3) colocalization with DNase X at entry foci during invasion, and 4) ultrastructure of entry process (filopodia, [4]). Some of these features are summarized in Table 1.
Table 1. Summary- Internalization of E. chaffeensis, rEtpE-C-coated or non-coated beads.
Candidate | Non-phagocytes1 | Phagocytes2 | DNase X−/−BMDMs | Drug3-pretreated host cells |
E. chaffeensis | Internalized | Internalized | Poorly Internalized | Not Internalized |
rEtpE-C-coated beads | Internalized | Internalized | Not Internalized | Not Internalized |
Non-coated beads | Not Internalized | Internalized | Internalized | Internalized |
HEK293 and RF/6A cells.
Human primary macrophages derived from blood monocytes, Canine primary macrophages derived from blood monocytes, DH82 cells, THP-1 cells, and mouse bone-marrow-derived macrophages (BMDMs).
MDC, genistein, verapamil, or PI-PLC.
Our results demonstrate that in the absence of any other bacterial proteins EtpE-C is sufficient to orchestrate the binding and entry of coated beads, and in extension E. chaffeensis binding and entry, into its host cells. Protein coating of latex beads has been widely used for phagocytosis study [34] and also been previously utilized for studies with Listeria internalin [35]. For studying rickettsial adhesins and invasins, Escherichia coli-based heterologous protein expression system has been utilized [36], [37]. Using latex beads coated with rickettsial proteins provides an alternative way to study rickettsial invasin. The method is especially useful for those proteins poorly expressed on E. coli surface and/or when using host cells, such as macrophages, that are easily perturbed by E. coli.
Function of EtpE-C as an E. chaffeensis invasin mediating its DNase X-dependent entry of host cells is strongly supported by in vitro and in vivo anti-EtpE-C neutralization results, and in vitro and in vivo requirement of DNase X for efficient E. chaffeensis infection. The results suggest E. chaffeensis invasion process, like inert rEtpE-C-coated latex beads, does not require bacterial energy. Adhesion alone seems to be sufficient in triggering cellular receptor-mediated signaling pathways resulting in filopodial extension and internalization. This is distinct from the triggering of bacterial uptake by the action of actively injected bacterial type III secretion system effector molecules [38], [39], but in agreement with the condensed and resistant features of E. chaffeensis DCs capable of invasion [18]. This also is in agreement with the regulation of EtpE expression by a DNA binding protein BolA, which is in turn regulated by CtrA, a response regulator of the two-component system [18]. E. chaffeensis CtrA positively regulates genes involved in the development of the resistant phenotype, at the late stage of E. chaffeensis growth cycle, when RCs convert to DCs [18]. The rosary-like pattern of EtpE in host cell surface-bound E. chaffeensis did not preexist in host cell-free E. chaffeensis; thus might be induced by its engagement with cell surface DNase X upon binding. Significance of this change in EtpE surface distribution awaits further investigation.
Although both EtpE-N and EtpE-C were conserved among E. chaffeensis strains, only EtpE-C mediated binding and entry into non-phagocytes, indicating functional specificity of this segment. In addition to the poor accessibility of anti-EtpE-N to its target on live E. chaffeensis surface, the inability of EtpE-N to function as an invasin seems to be the primary reason for the weak in vitro neutralization of E. chaffeensis infection with anti-EtpE-N. While both EtpE-N and EtpE-C fragments were recognized and elicited humoral immune response in naturally infected humans and experimentally infected dogs, it seems that the antibody titer to EtpE-C is lower than to EtpE-N. This lower titer may help E. chaffeensis to establish infection. Although the present study did not probe the function of the central region of EtpE, being variable among E. chaffeensis strains, this segment of the protein may be under selective pressure in the host for E. chaffeensis to persist in nature. Although EtpE is found in all Ehrlichia spp., amino acid sequences corresponding to EtpE-C are not conserved among EtpE orthologs of Ehrlichia spp.; whether these orthologs also serve as adhesins/invasins in other Ehrlichia sp. remain to be studied.
The present study showed that not only antibody against rEtpE-C neutralizes E. chaffeensis infection in vitro, but also immunization of mice with rEtpE-C confers protection against E. chaffeensis challenge. It has been reported that adoptive transfer of immune serum from immunocompetent C57BL/6 mice to immuno-compromised SCID mice confers significant protection from fatal E. chaffeensis infection [36]. Mice with depleted complements, or lacking B cells, FcγR1, CR1, CR2, or Nox2 (a subunit of NADPH oxidase) are more susceptible to non-lethal dose infection with the HF strain of Ehrlichia (Ixodes ovatus Ehrlichia) that is closely related to E. chaffeensis [28]. N. risticii infects P388D1 macrophages, but FcR-mediated entry kills this bacterium and Fab fragment of the immune IgG blocks binding and entry of N. risticii [37]. Whether any of these mechanisms are involved in protection of mice from E. chaffeensis infection by rEtpE-C immunization awaits further study. Nonetheless, our results from in vitro neutralization studies suggest a direct inhibition of E. chaffeensis binding by anti-EtpE-C antibody and support the importance of antibodies in ehrlichial immunity. A recent study showed that EtpE mRNA is highly expressed by E. chaffeensis in cell lines derived from the ticks, Amblyomma americanum and Ixodes scapularis using E. chaffeensis genome microarrays [38]. Since E. chaffeensis is transmitted between mammals by tick bite, expression of EtpE in tick cells suggests an indispensable role for this protein throughout the E. chaffeensis life cycle.
DNase X-mediated uptake is the first entry pathway to be uncovered for Ehrlichia spp. Compared to DNase I, DNase X has an extra hydrophobic stretch at its C-terminus [32]. This C-terminal stretch is conserved in all mammalian DNase X proteins examined, and required for GPI-anchoring to the plasma membrane [33], [40]. Cellular functions of DNase X are not understood well. There is no obvious defect in DNase X−/− mice and their reproduction is normal [41]. DNase X was never reported to serve as a receptor for any infectious agents. –Overexpression of DNase X enhances degradation of the exogenous plasmid DNA, consequently suppressing transformation in RD myotubes; whereas siRNA-mediated DNase X knockdown reverses this inhibition [33]. DNase X is, therefore, considered as a barrier in naked DNA transfer [33].
rEtpE-C-coated beads, unlike non-coated beads or rECH0825-coated beads, were unable to bind or enter DNase X−/− BMDMs. Un-opsonized non-coated latex beads are taken up by macrophages predominantly via scavenger receptors [42]–[44]. This suggests that rEtpE-C-coating not only made beads to bind DNase X, but also to repel or avoid the scavenger receptor recognition. The detailed mechanism underlying this phenomenon remains to be clarified.
The EtpE-DNase X-mediated entry of host cells by E. chaffeensis seems to be by a ‘zipper mechanism’ [39] initiated by specific contacts between bacterial ligand and host cell surface receptor and sequential engagement of the host cell surface membrane against bacterial surface. A schematic representation of a working model for E. chaffeensis binding and invasion of its target cells is depicted in Fig. 8. The initial binding and engagement of DNase X in the lipid-raft enriched areas on the host cell surface by EtpE C-terminal region causes clustering and lateral re-distribution of DNase X molecules to the site of E. chaffeensis attachment. This binding elicits signals that culminate in host cytoskeletal remodeling, filopodial formation embracing the bacteria and engulfment of the bound bacteria into an early endosome in the host cell. This receptor-mediated endocytosis can be specifically disrupted by genistein, verapamil or MDC.
Among members of the order Rickettsiales, the bacterial ligand and the cognitive host cell receptor pair for invasion have been reported only for Rickettsia conorii using in vitro cultured cells. For invasion, R. conorii uses an autotransporter protein OmpB as the ligand and Ku70, one of the DNA-binding components of the DNA-dependent protein kinase of mammalian cells as the receptor [45]. Whether Ku70 is required for in vivo infection by Rickettsia spp. is unknown. OmpB was originally identified as an invasive rickettsial protein capable of mediating binding and entry of host cells in R. japonica, another spotted fever group Rickettsia closely related to R. conorii [36]. Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis, binds to fucosylated P-selectin glycoprotein ligand-1 (PSGL-1) as a key initial receptor component [46]. α1,3-fucose is critical for A. phagocytophilum to infect neutrophils in mice and for the bacterium to colonize ticks [47], [48]. α2,3-sialic acid at the PSGL-1 N-terminus was identified as the receptor for an A. phagocytophilum adhesin, the peptidoglycan-associated lipoprotein, OmpA [49]. The present study identifies the first Ehrlichia invasin-receptor pair and is a critical advancement as this provides the first evidence for the importance of a given invasin-receptor pair in vivo for any pathogens belonging to the order Rickettsiales. In contrast to the almost complete abrogation of entry of rEtpE-C-coated beads into DNase X−/− BMDMs, E. chaffeensis entry into DNase X−/− BMDMs was reduced by 60% compared to wild-type BMDMs. This suggests existence of additional mammalian receptors for E. chaffeensis infection. Similarly R. conorii invasion of embryonic fibroblasts derived from Ku70−/− mice is reduced by 50% compared to the cells derived from the wild-type litter mates [45]. A recent report has shown that E. coli expressing another autotransporter protein of R. conorii, OmpA, can invade endothelial cells by interacting with α2β1 integrin [50]. Rickettsial OmpA was originally suggested as an adhesin in R. rickettsii [51]. Although Rickettsia and Ehrlichia spp. are phylogenetically related (both belong to the order Rickettsiales), and share similar wild animal reservoirs and vector ticks in nature, E. chaffeensis EtpE and R. conorii invasin OmpB/OmpA are uniquely evolved in them, respectively [52]. This perhaps enabled these bacteria to utilize independent host surface receptors: DNase X and Ku70, respectively, for invasion to infect broader host range and cytoplasmic niche.
In light of severe and potentially fatal outcomes of HME, the limited choice of antibiotics and lack of prophylactic measures, further understanding of invasion mechanisms is of great importance. Such information will assist in the development of new preventive and therapeutic measures against HME and similar diseases by specific pharmacological or immunologic disruption of invasin and the host cell receptor interaction.
Materials and Methods
Ethics statement
All animal experiments were performed in accordance with The Ohio State University Institutional Animal Care and Use Committee guidelines and approved e-protocol numbers 2009A0186 and 2008A0066. The University program has Full Continued Accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC-I) under #000028 dated June 9, 2000 and has a Public Health Services assurance renewal #A3261-01 dated February 5, 2007 through February 28, 2015. The program is licensed by the USDA, #1-R-014, and is in full compliance with Animal Welfare Regulations.
E. chaffeensis and host cell culture
E. chaffeensis Arkansas type strain was propagated in DH82 cells, and host cell–free E. chaffeensis was obtained by controlled sonication as described [53], [54]. Human peripheral blood monocytes were derived from buffy coats; HEK293, RF/6A and THP-1 cells were cultured as previously described [7], [8], [54]. BMDMs were established from wild-type and DNase X −/− mice as described [8].
Mouse infection studies
Two groups of C3H/HeJ mice (4-week-old females; 4 mice per group) (Jackson Laboratories) received either minced SDS-polyacrylamide gel containing 50 µg of rEtpE-C or minced gel alone, with Quil A (Accurate Chemicals) as adjuvant for a total of three times at 14-day intervals. E. chaffeensis challenge was performed 10 days following the last immunization as described [21]. DNase X−/− [41] and congenic wild-type C57BL/6 mice (5- to 6-week-old females; 5 mice per group) were inoculated intraperitoneally with E. chaffeensis-infected THP-1 cells (>90% cells infected; 6×105 cells/mouse). DNA was extracted from blood samples using a QIAamp blood kit (Qiagen), and subjected to qPCR using E. chaffeensis 16S rDNA and mouse glyceraldehyde 3-phosphate dehydrogenase (G3PDH) gene primers.
Production of recombinant proteins rEtpE-N and rEtpE-C, and antisera against them
DNA fragments encoding EtpE-C and EtpE-N were amplified by PCR with Phusion high-fidelity DNA polymerase (NEB) using E. chaffeensis chromosomal DNA as template. The fragments were cloned into pET33b(+) vector (Novagen); recombinant proteins were expressed in E. coli BL21 (DE3) and purified by Ni-affinity chromatography. The antibody against rEtpE-C was produced in ICR mice (Harlan), and the antibody against rEtpE-N was produced in rabbits.
Western blot analysis with sera from HME patients and E. chaffeensis-infected dogs
Affinity-purified rEtpE-C and rEtpE-N (5 µg each) were subjected to SDS-PAGE, transferred to a nitrocellulose membrane, and incubated with sera from E. chaffeensis-infected dogs (CTUALJ, 3918815, 1425) [28], HME patients (ID: MRL1-22, MRL1-40, 72088) [27], or control sera. After washing, the membranes were incubated with horseradish peroxidase–conjugated goat anti-dog or anti-human IgG (KPL). Reacting bands were visualized with enhanced chemiluminescence (ECL), images were captured and densitometric analysis was performed using an LAS3000 image documentation system (FUJIFILM Medical Systems).
Yeast two-hybrid screening
Yeast two-hybrid screening was performed using Matchmaker Two-Hybrid System (Clontech) according to manufacturer's instructions. The bait plasmid pGBKT7-EtpE-C was constructed by the fusion of EtpE-C with the GAL4 DNA-binding domain in pGBKT7 (Clontech) by PCR. EtpE-C coding sequence was amplified using the forward primer 5′-AATCCATGGAATTGTTGTCATTAGTTGGTGGGCATCG-3′ (5′ NcoI site underlined) and reverse primer 5′-TCGACGGATCCAATCCCCTTCCAGCATTAATTTTATCAAAGG-3′ (5′ BamHI site underlined), and the product was ligated into pGBKT7. pGBKT7-EtpE-C was transformed into Saccharomyces cerevisiae strain AH109 and selected by the ability to grow on SD agar plates lacking tryptophan. The expression of bait protein EtpE-C in yeast was examined by Western blotting. The human bone marrow MATCHMAKER cDNA library (Clontech) that was fused with GAL4-activating domain in pGADT7 was transformed in S. cerevisiae strain Y187 (Clontech). Library clones expressing interacting prey proteins were screened with yeast mating. Positive clones were selected by their ability to grow on SD quadruple drop-out (SD/QDO) plates lacking adenine, histidine, leucine, and tryptophan, and verified on SD/QDO plates containing X-gal. Positive clones were then isolated, and the prey plasmids were purified and sequenced after they were transformed into E. coli TOP10F′ competent cells (Invitrogen). The interaction was confirmed by re-shuttling the purified prey plasmid into S. cerevisiae AH109 transformed with bait plasmid and by nutritional selection in SD/QDO plates.
Binding and internalization assay of E. chaffeensis and immunostaining of host cell-free E. chaffeensis
Coverslip cultures of DH82, HEK293, RF/6A cells, or macrophages differentiated from human peripheral blood monocytes or established from bone-marrow of DNase X−/− or congenic wild-type mice and suspension culture of THP-1 cells were incubated with E. chaffeensis freshly isolated from infected cells at approximate multiplicity of infection (MOI) of 200, unless otherwise noted, for 30 to 45 min for binding assays or 2 to 4 h for internalization assays at 37°C in 5% CO2/95% air. Cells were washed with phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1 mM KH2PO4, pH 7.4) to remove unbound bacteria and labeled with antibodies as described [23]. For binding assay cells were fixed with 3% PFA and labeled with mouse monoclonal anti-DNase X (Abcam), rabbit anti-E. chaffeensis P28 [21], mouse anti-rEtpE-C, or dog anti-E. chaffeensis [55] as primary antibodies and Alexa Fluor (AF) 488–conjugated goat anti-mouse IgG, AF555–conjugated goat anti-rabbit IgG (Invitrogen), or Texas Red–conjugated goat anti-dog IgG (Jackson ImmunoLab) as secondary antibodies. For internalization assays, two steps of labeling of fixed cells with anti-P28 were carried out as described: the first labeling step was performed without saponin permeabilization using AF488–conjugated goat anti-rabbit IgG, and the second labeling was performed with permeabilization using AF555–conjugated goat anti-rabbit IgG [56]. Fluorescent images were acquired using a Nikon Eclipse E400 fluorescence microscope with a xenon-mercury light source (Nikon), Deltavision deconvolution microscope (Applied Precision) with 0.2 or 0.4-µm step size along the z-axis of the cells, or an LSM 510 laser-scanning confocal microscope (Carl Zeiss). For immunostaining of live bacteria, host cell-free E. chaffeensis was incubated with anti-EtpE-C, anti-EtpE-N or E. chaffeensis P28 for 1 h at room temperature followed by fixing with 3% PFA and labeling with AF555-conjugated goat anti-mouse or anti-rabbit antibodies. To further demonstrate the surface exposure of EtpE, host cell-free E. chaffeensis was incubated with either pronase E (Sigma) at a concentration of 2 mg/ml in PBS or vehicle control for 15 min at 37°C [57]; pronase E was inactivated by adding 10% fetal bovine serum (FBS), followed by washing in PBS twice. The bacteria were cytospun onto glass slides, fixed with 3% PFA, followed by quenching in PBS containing 0.1 M glycine, washed with PBS and labeled sequentially with anti-EtpE-C and anti-CtrA [18] with or without saponin permeabilization followed by AF488 or AF555-conjugated goat anti-mouse or anti-rabbit antibodies.
[35S]methionine-labeled E. chaffeensis binding and uptake
Approximately 106 cells of E. chaffeensis-infected THP-1 cells/ml in 2 ml of methionine cysteine-deficient RPMI 1640 medium (ICN Biomedicals) supplemented with 10% FBS and 2 mM l-Gln were incubated with cycloheximide (Sigma) at 10 µg/ml at 37°C for 1 h. A metabolic labeling reagent (Tran 35S-Label; 11.7 mCi/ml [1,100 Ci/mmol]; 100 µl; ICN Biomedicals) was added and the mixture was incubated further at 37°C for 24 h. The radiolabeled E. chaffeensis was released by sonication and washed by centrifugation at 10,000×g for 10 min. To study the effect of rabbit anti-P28 on E. chaffeensis binding and entry, radiolabeled E. chaffeensis cells (40,000 cpm/200 µl) preincubated with Fab fragment of anti-P28 IgG [0.5 mg/ml, prepared using Immobilized papain (Pierce) from IgG affinity purified with AffiPack Immobilized Protein A column (Pierce)] or Fab fragment of normal rabbit IgG (0.5 mg/ml) were added to 1×106 THP-1 cells in 0.4 ml of RPMI 1640 medium containing 10% FBS and 2 mM l-Gln and incubated at 4°C for 2 h. The uptake of E. chaffeensis was evaluated following removal of bound E. chaffeensis cells by incubation with pronase E at 2 mg/ml in PBS at 37°C for 10 min after incubation of E. chaffeensis with THP-1 cells at 37°C for 3 h. THP-1 cells were washed by centrifugation at 375×g for 5 min, the cells then were dissolved in 0.6 N NaOH and 0.5% SDS, and the radioactivity was measured in a scintillation counter.
In vitro neutralization and RNA interference
E. chaffeensis preincubated with 25 µg/ml of mouse anti-rEtpE-C, rabbit anti-rEtpE-N, or preimmune mouse or rabbit sera for 1 h at 4°C were used to infect THP-1, RF/6A, or DH82 cells. Alternatively, E. chaffeensis was added to DH82 cells preincubated with 10 µg/ml of monoclonal anti-DNase X or control mouse monoclonal antibody for 30 min at 25°C in serum-free DMEM. Binding, internalization, and infection were determined at 30 min, 2 h and 48 h pi, respectively. HEK293 cells in 24-well plates were transfected with 50 nM DNase X siRNA (Santa Cruz Biotechnology) or scrambled control siRNA using Lipofectamine 2000 (Invitrogen). A second transfection with 50 nM of DNase X and scrambled siRNAs was performed 30 h after the first transfection. An aliquot of cells were harvested at 24 h after the second transfection to determine the protein amount of DNase X by Western blotting and densitometry analysis with anti-DNase X and rabbit anti-actin (Sigma). The other aliquot of cells were incubated with E. chaffeensis and incubated for an additional 48 h to evaluate infection. Infection was determined by qPCR of E. chaffeensis 16S rRNA gene relative to host cell G3PDH gene [18].
Far-Western blotting, protein affinity pull-down and co-immunoprecipitation
Far-Western blotting was performed using 5 µg of rEtpE-C and rECH0825 that were separated by SDS-PAGE, transferred to a nitrocellulose membrane and renatured with serial guanidinium-HCl treatment followed by incubation with THP-1 cell lysate in NP-40 lysis buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.4, 1% w/v NP-40, supplemented with 1% protease inhibitor cocktail set III [Calbiochem]) as described [58]. After stringent washing, the membrane was incubated with anti-DNase X and peroxidase-conjugated goat anti-mouse antibodies (KPL). The membrane was stripped with Restore Western Blot Stripping Buffer (Thermo scientific) and reprobed with peroxidase-conjugated anti-histidine antibody (Sigma). For protein pull-down, His-tagged rEtpE-C was bound to and renatured on the Ni-affinity matrix (Promega). THP-1 cell lysate in NP-40 lysis buffer was applied to the matrix and incubated for 8 h at 4°C. After washing off the unbound or non-specifically bound proteins from the matrix, rEtpE-C and bound protein complex were eluted with 250 mM imidazole. The eluate and the post-elution Ni-matrix were resuspended in 2× SDS-sample buffer and subjected to Western blotting with anti-DNase X antibody. For co-immunoprecipitation assay, THP-1 cells were incubated with E. chaffeensis for 30 min and lysed in NP-40 lysis buffer. The lysate was immunoprecipitated with anti-EtpE-C (2 µg)-bound protein A agarose or control mouse IgG (2 µg)-bound agarose beads. The precipitate was resuspended in 2× SDS-sample buffer and subjected to Western blotting with anti-DNase X antibody.
Binding and internalization of latex beads
Sulfate-modified fluorescent red polystyrene beads (0.5 µm diameter; Sigma) at 3–4×106 beads in 200 µl of 25 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH 8.0 were incubated with 1 µg of rEtpE-C or rEtpE-N proteins in 5–7 µl 7 M urea in 50 mM sodium phosphate buffer, pH 7.2 at 4°C overnight with mixing at 20 rpm. MES buffer (150 µl) was sequentially added to the mixture every 15 min and incubated at room temperature, rotating at 20 rpm eventually diluting to around 200 times the original volume of urea buffer. rECH0825 and rGroEL were treated similarly, but without urea. The coated beads were collected by low speed centrifugation, washed twice in MES buffer and resuspended in complete DMEM or advanced MEM media, then gently sonicated to disperse the beads. Protein coating of the beads were confirmed by dot blot assay and/or immunofluorescence labeling. Freshly prepared protein-coated or non-coated beads were added at a multiplicity of approximately 50 beads per cell for co-localization studies and 500 beads per cell for quantitation of binding and internalization studies. The beads were incubated with HEK293 or RF/6A cells for 1 h at 37°C. Unbound beads were removed by washing and cells were fixed for immunofluorescence labeling to detect the localization of DNase X or EEA1 (anti-EEA1, BD). To study the effect of MDC, genistein, or verapamil on bead internalization, RF/6A cells were incubated with these chemicals at a final concentration of 100 µM or 0.1% DMSO solvent control for 30 min, then with rEtpE-C-coated beads for 8 h at 37°C. BMDMs from wild-type mice were pre-incubated with MDC or genistein (100 µM), PI-PLC (5 U/ml) or 0.1% DMSO for 30 min and then incubated with rEtpE-C-coated or non-coated beads for 45 min at 37°C. PI-PLC-treated cells were washed prior to addition of rEtpE-C-coated beads. The cells were washed and treated with 0.25% trypsin at 37°C for 10 min to remove surface-bound beads. The detached cells were further washed by low-speed centrifugation and later cytocentrifuged onto a glass slide and fixed with 3% PFA to observe internalized beads. To estimate the number of bound beads, a similar procedure for observing internalized beads was followed except that the beads were incubated with BMDM for 30 min at 4°C and following incubation the cells were washed to remove loosely bound beads and directly fixed with 3% PFA without trypsin treatment. For scanning electron microscopy, rEtpE-C-coated beads were incubated with RF/6A cells for 2 h at 37°C and processed as described previously [59]. For transmission electron microscopy, coated beads were incubated with RF/6A cells for 8 h at 37°C and processed as described previously [60]. The 3D orthogonal view of the cell to show spatial distribution of DNase X with beads was obtained by using the volume viewer function of SoftWoRx DeltaVision image acquisition software from Applied Precision.
Live-cell imaging
RF/6A cells were cultured in 35-mm glass bottom dishes (Wilco), transfected with DNase X-GFP, and incubated with rEtpE-C-coated beads at 4°C for 1 h to facilitate bead binding, but prevent internalization. Unbound beads were washed off, cells were replenished with medium lacking phenol red, and the samples moved to a controlled environmental chamber at 37°C with under 5% CO2/95% air. Time-lapse images were acquired at an interval of 10 s for 5 to 20 min through a 60×1.42 NA oil immersion lens with an inverted Olympus IX-70 microscope, in 0.4-µm steps in the z-axis using the attached Applied Precision motorized stage (DeltaVision deconvolution microscope). All stacks of images were deconvoluted using SoftWoRx software and the time-lapse images of a single focal plane of 0.4-µm focal depth at the cell surface were exported as a video.
Statistical analysis
Statistical analysis was performed by unpaired two-tailed Student's t-test. P<0.05 was considered to be significant.
Supporting Information
Acknowledgments
We gratefully acknowledge Dr. Gerhard Rogler at Universitäts Spital Zürich for providing DNase X−/− mice. We appreciate former Rikihisa lab members, Yilan Zhang and Norio Ohashi for anti-P28 neutralization data, other Rikihisa lab members for their helpful advice and Tracy Hemmerly for helpful suggestions with the manuscript. We thank Mr. Tim Vojt for assistance in preparing Fig. 8.
Funding Statement
This study was supported by an NIH grant R01AI30010 and R01AI047885. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Paddock CD, Childs JE (2003) Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev 16: 37–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Rikihisa Y (2010) Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Nat Rev Microbiol 8: 328–339. [DOI] [PubMed] [Google Scholar]
- 3. Popov VL, Chen SM, Feng HM, Walker DH (1995) Ultrastructural variation of cultured Ehrlichia chaffeensis . J Med Microbiol 43: 411–421. [DOI] [PubMed] [Google Scholar]
- 4. Zhang JZ, Popov VL, Gao S, Walker DH, Yu XJ (2007) The developmental cycle of Ehrlichia chaffeensis in vertebrate cells. Cell Microbiol 9: 610–618. [DOI] [PubMed] [Google Scholar]
- 5. Cheng Z, Wang X, Rikihisa Y (2008) Regulation of type IV secretion apparatus genes during Ehrlichia chaffeensis intracellular development by a previously unidentified protein. J Bacteriol 190: 2096–2105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Mott J, Barnewall RE, Rikihisa Y (1999) Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect Immun 67: 1368–1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Liu H, Bao W, Lin M, Niu H, Rikihisa Y (2012) Ehrlichia type IV secretion effector ECH0825 is translocated to mitochondria and curbs ROS and apoptosis by upregulating host MnSOD. Cell Microbiol 14: 1037–1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Miura K, Matsuo J, Rahman MA, Kumagai Y, Li X, et al. (2011) Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-kappaB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors. Infect Immun 79: 4947–4956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Dunning Hotopp JC, Lin M, Madupu R, Crabtree J, Angiuoli SV, et al. (2006) Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet 2: e21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Krieger M (1997) The other side of scavenger receptors: pattern recognition for host defense. Curr Opin Lipidol 8: 275–280. [DOI] [PubMed] [Google Scholar]
- 11. Lin M, Zhu MX, Rikihisa Y (2002) Rapid activation of protein tyrosine kinase and phospholipase C-gamma2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells. Infect Immun 70: 889–898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Levitzki A, Willingham M, Pastan I (1980) Evidence for participation of transglutaminase in receptor-mediated endocytosis. Proc Natl Acad Sci U S A 77: 2706–2710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Messick JB, Rikihisa Y (1993) Characterization of Ehrlichia risticii binding, internalization, and proliferation in host cells by flow cytometry. Infect Immun 61: 3803–3810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Schlegel R, Dickson RB, Willingham MC, Pastan IH (1982) Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. Proc Natl Acad Sci U S A 79: 2291–2295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Lin M, Rikihisa Y (2003) Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell Microbiol 5: 809–820. [DOI] [PubMed] [Google Scholar]
- 16. Pizarro-Cerda J, Cossart P (2006) Bacterial adhesion and entry into host cells. Cell 124: 715–727. [DOI] [PubMed] [Google Scholar]
- 17. Miura K, Rikihisa Y (2007) Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect Immun 75: 3604–3613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Cheng Z, Miura K, Popov VL, Kumagai Y, Rikihisa Y (2011) Insights into the CtrA regulon in development of stress resistance in obligatory intracellular pathogen Ehrlichia chaffeensis . Mol Microbiol 82: 1217–1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Dawson JE, Anderson BE, Fishbein DB, Sanchez JL, Goldsmith CS, et al. (1991) Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 29: 2741–2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Paddock CD, Sumner JW, Shore GM, Bartley DC, Elie RC, et al. (1997) Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol 35: 2496–2502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Ohashi N, Zhi N, Zhang Y, Rikihisa Y (1998) Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family. Infect Immun 66: 132–139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kumagai Y, Huang H, Rikihisa Y (2008) Expression and porin activity of P28 and OMP-1F during intracellular Ehrlichia chaffeensis development. J Bacteriol 190: 3597–3605. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Wang X, Kikuchi T, Rikihisa Y (2006) Two monoclonal antibodies with defined epitopes of P44 major surface proteins neutralize Anaplasma phagocytophilum by distinct mechanisms. Infect Immun 74: 1873–1882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17: 593–623. [DOI] [PubMed] [Google Scholar]
- 25. Crocquet-Valdes PA, Thirumalapura NR, Ismail N, Yu X, Saito TB, et al. (2011) Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis. Clin Vaccine Immunol 18: 2018–2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Bagos PG, Liakopoulos TD, Spyropoulos IC, Hamodrakas SJ (2004) PRED-TMBB: a web server for predicting the topology of beta-barrel outer membrane proteins. Nucleic Acids Res 32: W400–404. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Unver A, Rikihisa Y, Ohashi N, Cullman LC, Buller R, et al. (1999) Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens. J Clin Microbiol 37: 3888–3895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Huang H, Lin M, Wang X, Kikuchi T, Mottaz H, et al. (2008) Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteins. Infect Immun 76: 3405–3414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Yager E, Bitsaktsis C, Nandi B, McBride JW, Winslow G (2005) Essential role for humoral immunity during Ehrlichia infection in immunocompetent mice. Infect Immun 73: 8009–8016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Telford SR (1996) Persistent infection of C3H/HeJ mice by Ehrlichia chaffeensis . Vet Microbiol 52: 103–112. [DOI] [PubMed] [Google Scholar]
- 31. Werb Z, Cohn ZA (1972) Plasma membrane synthesis in the macrophage following phagocytosis of polystyrene latex particles. J Biol Chem 247: 2439–2446. [PubMed] [Google Scholar]
- 32. Shiokawa D, Tanuma S (2001) Characterization of human DNase I family endonucleases and activation of DNase gamma during apoptosis. Biochemistry 40: 143–152. [DOI] [PubMed] [Google Scholar]
- 33. Shiokawa D, Matsushita T, Shika Y, Shimizu M, Maeda M, et al. (2007) DNase X is a glycosylphosphatidylinositol-anchored membrane enzyme that provides a barrier to endocytosis-mediated transfer of a foreign gene. J Biol Chem 282: 17132–17140. [DOI] [PubMed] [Google Scholar]
- 34. McAbee DD, Grinnell F (1983) Fibronectin-mediated binding and phagocytosis of polystyrene latex beads by baby hamster kidney cells. J Cell Biol 97: 1515–1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Lecuit M, Ohayon H, Braun L, Mengaud J, Cossart P (1997) Internalin of Listeria monocytogenes with an intact leucine-rich repeat region is sufficient to promote internalization. Infect Immun 65: 5309–5319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Uchiyama T (2003) Adherence to and invasion of Vero cells by recombinant Escherichia coli expressing the outer membrane protein rOmpB of Rickettsia japonica . Ann N Y Acad Sci 990: 585–590. [DOI] [PubMed] [Google Scholar]
- 37. Cardwell MM, Martinez JJ (2009) The Sca2 autotransporter protein from Rickettsia conorii is sufficient to mediate adherence to and invasion of cultured mammalian cells. Infect Immun 77: 5272–5280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Alonso A, Garcia-del Portillo F (2004) Hijacking of eukaryotic functions by intracellular bacterial pathogens. Int Microbiol 7: 181–191. [PubMed] [Google Scholar]
- 39. Swanson JA, Baer SC (1995) Phagocytosis by zippers and triggers. Trends Cell Biol 5: 89–93. [DOI] [PubMed] [Google Scholar]
- 40. Shiokawa D, Shika Y, Saito K, Yamazaki K, Tanuma S (2005) Physical and biochemical properties of mammalian DNase X proteins: non-AUG translation initiation of porcine and bovine mRNAs for DNase X. Biochem J 392: 511–517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Rashedi I (2008) The Role of DNase X in Skeletal Muscle Addressed by Targeted Disruption of the Gene in a Mouse Model. Winnipeg: University of Manitoba. 122.
- 42. Kobzik L (1995) Lung macrophage uptake of unopsonized environmental particulates. Role of scavenger-type receptors. J Immunol 155: 367–376. [PubMed] [Google Scholar]
- 43. Palecanda A, Paulauskis J, Al-Mutairi E, Imrich A, Qin G, et al. (1999) Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med 189: 1497–1506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Palecanda A, Kobzik L (2001) Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors. Curr Mol Med 1: 589–595. [DOI] [PubMed] [Google Scholar]
- 45. Martinez JJ, Seveau S, Veiga E, Matsuyama S, Cossart P (2005) Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii . Cell 123: 1013–1023. [DOI] [PubMed] [Google Scholar]
- 46. Herron MJ, Nelson CM, Larson J, Snapp KR, Kansas GS, et al. (2000) Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science 288: 1653–1656. [DOI] [PubMed] [Google Scholar]
- 47. Carlyon JA, Akkoyunlu M, Xia L, Yago T, Wang T, et al. (2003) Murine neutrophils require alpha1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum . Blood 102: 3387–3395. [DOI] [PubMed] [Google Scholar]
- 48. Pedra JH, Narasimhan S, Rendic D, DePonte K, Bell-Sakyi L, et al. (2010) Fucosylation enhances colonization of ticks by Anaplasma phagocytophilum . Cell Microbiol 12: 1222–1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Ojogun N, Kahlon A, Ragland SA, Troese MJ, Mastronunzio JE, et al. (2012) Anaplasma phagocytophilum outer membrane protein A interacts with sialylated glycoproteins to promote infection of mammalian host cells. Infect Immun 80: 3748–3760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Hillman RD Jr, Baktash YM, Martinez JJ (2013) OmpA-mediated rickettsial adherence to and invasion of human endothelial cells is dependent upon interaction with alpha2beta1 integrin. Cell Microbiol 15: 727–741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Li H, Walker DH (1998) rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microb Pathog 24: 289–298. [DOI] [PubMed] [Google Scholar]
- 52. Ogata H, Audic S, Renesto-Audiffren P, Fournier PE, Barbe V, et al. (2001) Mechanisms of evolution in Rickettsia conorii and R. prowazekii . Science 293: 2093–2098. [DOI] [PubMed] [Google Scholar]
- 53. Rikihisa Y, Ewing SA, Fox JC (1994) Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans. J Clin Microbiol 32: 2107–2112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Barnewall RE, Rikihisa Y (1994) Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun 62: 4804–4810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Barnewall RE, Rikihisa Y, Lee EH (1997) Ehrlichia chaffeensis inclusions are early endosomes which selectively accumulate transferrin receptor. Infect Immun 65: 1455–1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Niu H, Rikihisa Y, Yamaguchi M, Ohashi N (2006) Differential expression of VirB9 and VirB6 during the life cycle of Anaplasma phagocytophilum in human leucocytes is associated with differential binding and avoidance of lysosome pathway. Cell Microbiol 8: 523–534. [DOI] [PubMed] [Google Scholar]
- 57. Yoshiie K, Kim HY, Mott J, Rikihisa Y (2000) Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun 68: 1125–1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Bao W, Kumagai Y, Niu H, Yamaguchi M, Miura K, et al. (2009) Four VirB6 paralogs and VirB9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles. J Bacteriol 191: 278–286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Thomas S, Popov VL, Walker DH (2010) Exit mechanisms of the intracellular bacterium ehrlichia. PLoS One 5: e15775. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Rikihisa Y, Ito S (1979) Intracellular localization of Rickettsia tsutsugamushi in polymorphonuclear leukocytes. J Exp Med 150: 703–708. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.